INTRODUCTION
Coronary arterial diseases are one of the increasingly common chronic diseases around the worldwide. Both selective and non-selective adrenergic receptor blockers, especially selective β1-adrenoceptor antagonists, are often used to treat cardiovascular disease, even when complicated by chronic obstructive pulmonary disease. 1 Most studies reported that sexual adverse effects were increased as if lumbal sympathectomy was performed by increasing clinical use of beta-blockers. [2] [3] [4] These adverse effects of beta-blockers are considered that depends on their chemical structure. Sexual adverse effects are more common in propranolol which has lipophilic structure. 5, 6 Propranolol is a β1-β2 selective receptor blockers. Most studies revealed that propranolol had a histopathologically toxic effect on the testis. Animal model studies showed that propranolol could involve degeneration, necrosis, fibrosis, hypocellularity in germinal epithelium and dystrophic calcification in seminiferous tubules. It is considered that beta blockers impair spermatogenesis via β2-receptors. 7, 8 Metoprolol is a selective β1-adrenergic antagonist, extensively used since 1975. Metoprolol has proven its efficacy in reducing cardiovascular events and mortality in patients with hypertension and coronary heart disease.9 So, it is considered that cardiovascular, respiratory and metabolic and also adverse effects are less than other beta-blockers. 10 Carvedilol is a α1/β-adrenoreceptors blocker, used in the treatment of hypertension and congestive heart failure.
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It selectively blocks α1-receptors, and non-selectively antagonizes β1 and β2-adrenoreceptors. 12 Carvedilol and some of its metabolites also display antioxidant activity. This antioxidant characteristic of carvedilol has been shown in previous in vitro studies and animal models. [13] [14] [15] [16] In the present study, we aimed to investigate the histopathological effect of the different kind adrenergic receptor blockers (propranolol, metoprolol, and carvedilol) on spermatogenesis, used the treatment of cardiovascular diseases, in rat testis.
METHODS

Animal study
Adult male Sprague Dawley rats weighed between 250-350g, were obtained from Karadeniz Technical University, Faculty of Medicine, Surgical Research Center, Animal Experiment Laboratory (Trabzon, Turkey). All animals received humane care according to the criteria outlined in the 'Guide for the Care and Use of Laboratory Animals' prepared by the National Academy of Sciences and published by the National Institutes of Health.
The study was approved by Karadeniz Technical University Animal Ethical Committee (2010/46). Animals were kept under controlled temperature (23±2 C) and relative humidity (60±10%) conditions, with a 12/12h light/dark cycle and fed lab chow and water ad libitum.
One day after the last treatment, rats were weighed and anesthetized. Totally 32 rats homogenized according to their weight and divided into four groups that each one includes eight rats. Three of groups were determined as drug groups, and remaining group was determined as a control group. Propranolol 40mg/kg, metoprolol succinate 60mg/kg, carvedilol 30mg/kg dosages were given by oral gavage within the saline solution, respectively. Saline solution was given to control group. All drugs and saline were given to experimental animals by oral gavage in every 24 hours. The application was continued 21 days. When 21 days completed, after a day, rats were sacrificed with high dosage ketamine. After a midline incision, testis was extracted from inguinal canal and epididymis were removed, then they were put in Bouin solution.
Histopathological procedure
Testis were fixed in Bouin solution for 24 hours. After paraffin blocks were prepared, 4-5 micron sections were performed and painted with Haematoxylin-Eosin (HandE). Sections were evaluated with Nikon E200 light microscope (Nikon, Tokyo, Japan). Histopathological evaluation criteria were performed according to references of Creasy's testis toxicity score method [16] . Toxicologic classification of the testis is summarized in Table 1 . 
Statistical analysis
The package used for statistical analyses was the SPSS Statistics 18.00 (IBM Inc., Chicago, USA). The testis weights data were expressed as a mean±standart deviation. Statistical analysis was performed using oneway analysis of variance followed by Tukey test (Table  2) . Histological damage Creasy's testis toxicity were expressed as a median±standart deviation. Statistical analysis was performed using nonparametric KruskalWallis test. Between groups differences were performed using Tamhane's T2 test (Table 4 ). (p<0.05, which is considered to be significant).
RESULTS
Testis weights results
No statistical significance were found between right and left testis weights in the all groups rat. There was statistical significance between control and carvedilol groups for both right and left testis. Results of all groups were summarized in (Table 4) , (Figure 1, 2) .
DISCUSSION
Beta-adrenergic receptor blockers bind its adrenergic receptors irreversible. So that, they antagonize the effect of sympathoadrenal system stimulation or beta mimetic (agonist) drugs on variable structures. There are two main types of Beta-receptors; β1 and β2 adrenergic receptors. Then, an atypical beta-receptor β3 and β4 receptor types were defined. Beta-adrenergic receptors have different affinity to various agonists and antagonists.
Figure 1: Representative light microscopic photographs from testis tissue sections stained with H and E. x10. A-Control group (normal histologic appearance), B-Propranolol, C-Metoprolol Succinate group, D-Carvedilol group. Seminiferous tubules (St).
Interstitial area (Int). Most important fundamental pharmacological properties of these drugs are their selectivity. Some Beta-blockers have an equally high affinity to β1 and β2 receptors and blocks both receptors equally. These drugs are described as non-selective beta-blockers. Propranolol is the most important example of these non-selective beta blockers.
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International Moreover, also, carvedilol is an example which blocks α1 receptor in addition to β1 and β2 receptors. However, there are some selective drugs which have higher affinity to β1 receptors compared against β2 receptors. Metoprolol succinate is a striking example of this drug. So that, these drugs have less adverse effects such as broncho-construction, vasoconstriction, and metabolic effects because do not block the β2 receptor.
Propranolol is a β1-β2 selective and complete antagonist. It has no intrinsic sympathomimetic activity. It is a lipophilic drug and turns to its active metabolite in the liver. It stabilizes the cell membrane against the depolarization by blocking the Na+ channels over the cytoplasmic membrane.
Carvedilol is a β1-β2 and α1 selective beta blocker. It has no intrinsic sympathomimetic activity and does not have a lipophilic structure like propranolol. It does not engage membrane stabilization. 17 Carvedilol is the almost completely blocked increased sympathetic activity, unlike other beta-antagonists. Also, carvedilol blocks presynaptic β2 stimulation and do not increase myocardial β1 receptor density like selective β1-blockers. 18 Metoprolol succinate, unlike propranolol and carvedilol, is a selective beta-blockers and blocking β1 receptors. According to this, it has a little adverse effect on the respiratory system, cardiovascular system, and metabolism, clinically. 19 It is thought that these adverse effects occur via β2 receptors. Toxic effects of propranolol on testis were demonstrated with several histopathological studies. It is conceivable that similar adverse effects could occur in the testis. 7, 8 Bandmann revealed in his study that atrophy on testis and loss of libido occurred after unilateral lumbal sympathectomy and sperm parameters decreased. 20 Increased sexual adverse effects similar to lumbal sympathectomy were reported after increasing clinical use of beta-blockers. 2, 3 Increased adverse effects of betablockers are seen to be due to their chemical properties. Sexual adverse effects can be seen more common with lipophilic beta-blockers like propranolol. 5, 6 Several studies reported the effect of beta-blockers on testis. Semczuk showed in his study on humans that sperm motility was decreased after 60 minutes from the application of propranolol and reported that increasing adverse effects were dose-dependent. 21 El-Sayed and colleagues searched the effect of oral beta-adrenergic receptor blockers on male fertility parameters. They gave oral metoprolol, propranolol, and atenolol to the rats for 60 days and measured testis, epididymis, seminal vesicle weight and sperm motility. They reported that atenolol did not affect testis, epididymis and seminal vesicle weight. After the last dose of drug application, they examined the sperm motility, and they also observed all three drugs reduced the percentage of sperm motility progressively. Sperm head and tail anomalies were increased in all treatment groups. However, testosterone levels were decreased in rats applied beta-blockers, but this effect of beta-blockers decrease after 60 days from stopping the drug. 22 Martinez and colleagues demonstrated that application of propranolol intraperitoneally in male rats results with impaired testicular histology, necrosis and desquamation in germinal cells in seminiferous tubules. 7 Liaqat and colleagues reported that 1mg, 2mg, and 4mg propranolol was applicated intraperitoneally during 60 days to 56 rats. Half of the experiments in every three groups were sacrificed on 60 th days, and the remaining half were sustained for 60 more days. In their study, they did not find a significant difference between testicular weight, seminiferous tubules sizes, and the Leydig cells numbers, but on histopathological examination, in the group given 4mg propranolol, degeneration in the seminiferous tubules, necrosis, fibrinous material increase, hypocellularity in germinal epithelium and dystrophic calcification were observed.
They reported that histopathological changes were returned after stopping the drug. 8 Hassan and colleagues revealed beta-blockers-induced focal seminiferous tubular destruction, degeneration, necrosis and fibrinous material increase in the testis. 23 Razzak and colleagues investigated the effects of pindolol and propranolol on spermatogenesis in dogs and demonstrated that it had adverse effects on sperm motility and morphology. They considered that these effects of beta-blockers decreased insulin secretion from the beta cells in the islets of Langerhans and caused increased blood sugar levels. 24 Alexender considered that toxic effect of propranolol on spermatogenesis and sperm maturation was based on vasoconstriction in testicular vessels. 25 Suzuki and colleagues reported similar results that effect of atenolol on spermatogenesis. 26 According to the data in the literature, beta-blockers have toxic effects on spermatogenesis and sperm maturation. It is considered that these effects are occurred by reduction of insulin secretion from the beta cells in the islets of Langerhans and vasoconstriction in testicular vessels. Additionally, there were studies showed that betablockers impaired sperm motility. It is revealed that propranolol damages to the germinal cells and causes defects in sperm head and tail. Similarly, studies on betablockers demonstrated the morphological deterioration on the structure of testis.
In this study, we investigated the histopathological effects of propranolol, metoprolol succinate and carvedilol in rat testis. Propranolol blocks β1-β2 receptors, metoprolol succinate, blocks β1 receptors, and carvedilol blocks β1-β2 and α1 receptors. We observed that carvedilol decreased testicular weight in rats. While there were no differences in the group of propranolol regarding testicular weights, we observed deterioration in testicular morphology and germ cells. We detected adverse changes in histopathological score according to Creasy's testis toxicity score. According to Creasy's testis toxicity score, in the group of metoprolol succinate, we demonstrated no significant changes in terms of morphology and weight. In the light of the data obtained, we consider that this adverse effect of beta-blockers on testis occurs via β2 receptors which carvedilol and propranolol block and metoprolol succinate do not.
There are certainly a few limitations that are worth noting with this study. The main limitation of our study is that this is a hispathological study. More assays such as MDA, GSH or SOD could be used to evaluate the oxidant and antioxidant effects and serum testosteron levels could be measured. Furthermore, the molecular mechanism of beta blockers need to be elucidated by further studies.
CONCLUSION
Propranolol and metoprolol succinate caused no significant changes in rat testis weights. It was observed that carvedilol caused a decrease in the weight of the testis. Beta-1 selective metoprolol succinate did not cause significant deterioration in testicular histology. Propranolol and carvedilol caused significant deterioration in testicular histology, and it was considered that these effects occurred via β2 receptors. So, we consider that wide clinical use of adrenergic receptor blockers, especially Beta-blockers, may result in infertility in male, but these effect of drugs are reversible.
